SC 13D

Company

Skye Bioscience, Inc.

Filed

January 30, 2018

Accession Number

0001640334-18-000198

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →